secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2022-09-23T23:59:59+00:00
Accession:  0001193125-22-250135
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics appoints Justin Trojanowski as Principal Accounting Officer, effective Sept 30
--------------------------------------------------------------------------------

- Pierre Lorenzo resigns as Corporate Controller, Treasurer, Principal Accounting Officer and Secretary, effective Sept 30, 2022; not due to any disagreement.
- Justin Trojanowski (34), previously Director, Finance and Assistant Controller, promoted to Corporate Controller, Treasurer and Principal Accounting Officer.
- Nicholas Maestas, VP Strategy and Finance, appointed as Secretary, effective Sept 30, 2022.
- Trojanowski holds a B.S. and M.B.A. in Accountancy from Providence College, is a CPA, and previously worked at Nektar Therapeutics and Ernst & Young.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312522250135/0001193125-22-250135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312522250135/d384496d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-250135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer